Abstract
Furin is a member of the proprotein convertase family, which is capable of cleaving the precursors of a wide variety of substrates including membrane-type 1 matrix metalloproteinase (MT1-MMP) proenzyme. c-Src is activated by growth factors, and has been linked with a poor prognosis in pancreatic cancer (PCa). Both c-Src and Furin play crucial roles in tumorigenesis, and the mechanism controlling their association is not understood. Modulation of the association between Furin and pro-MT1-MMP by c-Src inhibitor PP2 was evaluated by western blotting, assay of in vitro enzyme, co-immunoprecipitation (co-IP), and confocal immunofluorescence microscopy. Human platelet-derived growth factor BB (PDGF-BB) activated c-Src and induced c-Src-dependent association of Furin with pro-MT1-MMP in HPAC pancreatic cancer cells. Co-IP and confocal immunofluorescence assays revealed that c-Src interacts with Furin in vivo. The SH2 domain appeared to be important for c-Src interaction with Furin. In addition, we showed that Furin protein is tyrosine phosphorylated. Association between Furin and MT1-MMP is regulated by the tyrosine kinase c-Src.
Similar content being viewed by others
References
Thomas G (2002) Furin at the cutting edge: from protein traffic to embryogenesis and disease. Nat Rev Mol Cell Biol 3(10):753–766
Pesu M, Watford WT, Wei L et al (2008) T-cell-expressed proprotein convertase Furin is essential for maintenance of peripheral immune tolerance. Nature 455:246–250
Strongin AY (2010) Proteolytic and non-proteolytic roles of membrane type-1 matrix metalloproteinase in malignancy. Biochim Biophys Acta 1803(1):133–141
Poincloux R, Lizarraga F, Chavrier P (2009) Matrix invasion by tumour cells: a focus on MT1-MMP trafficking to invadopodia. J Cell Sci 122(Pt 17):3015–3024
Kajita M, Itoh Y, Chiba T et al (2001) Membrane-type 1 matrix metalloproteinase cleaves CD44 and promotes cell migration. J Cell Biol 153(5):893–904
Hotary KB, Allen ED, Brooks PC et al (2003) Membrane type I matrix metalloproteinase usurps tumor growth control imposed by the three-dimensional extracellular matrix. Cell 114(1):33–45
Kerkela E, Ala-aho R, Lohi J et al (2001) Differential patterns of stromelysin-2 (MMP-10) and MT1-MMP (MMP-14) expression in epithelial skin cancers. Br J Cancer 84(5):659–669
Hanke JH, Gardner JP, Dow RL et al (1996) Discovery of a novel, potent, and Src family-selective tyrosine kinase inhibitor. J Biol Chem 271(2):695–701
Acosta JJ, Munoz RM, Gonzalez L et al (2003) Src mediates prolactin-dependent proliferation of T47D and MCF7 cells via the activation of focal adhesion kinase/Erk1/2 and phosphatidylinositol 3-kinase pathways. Mol Endocrinol D17(11):2268–2282
Cheng M, Watson PH, Paterson JA et al (1997) Pro-protein convertase gene expression in human breast cancer. Int J Cancer 71(6):966–971
Bassi DE, Mahloogi H, Al-Saleem L et al (2001) Elevated Furin expression in aggressive human head and neck tumors and tumor cell lines. Mol Carcinog 31(4):224–232
Page RE, Klein-Szanto AJ, Litwin S et al (2007) Increased expression of the pro-protein convertase Furin predicts decreased survival in ovarian cancer. Cell Oncol 29(4):289–299
Dangi-Garimella S, Krantz SB, Barron MR et al (2011) Three-dimensional collagen I promotes gemcitabine resistance in pancreatic cancer through MT1-MMP-mediated expression of HMGA2. Cancer Res 71(3):1019–1028
Hart CE, Forstrom JW, Kelly JD et al (1988) Two classes of PDGF receptor recognize different isoforms of PDGF. Science 240(4858):1529–1531
Choudhury GG, Mahimainathan L, Das F et al (2006) c-Src couples PI 3 kinase/Akt and MAPK signaling to PDGF-induced DNA synthesis in mesangial cells. Cell Signal 18(11):1854–1864
Ebert M, Yokoyama M, Friess H et al (1995) Induction of platelet-derived growth factor A and B chains and over-expression of their receptors in human pancreatic cancer. Int J Cancer 62(5):529–535
Ishizawar R, Parsons SJ (2004) c-Src and cooperating partners in human cancer. Cancer Cell 6(3):209–214
Roskoski R Jr (2004) Src protein-tyrosine kinase structure and regulation. Biochem Biophys Res Commun 324(4):1155–1164
Acknowledgment
This work was supported by a grant (30873033) from the National Natural Science Foundation of PR China and grants from Major State Basic Research Development Program(2009CB521800; 2010CB529400).
Conflict of interest
None.
Author information
Authors and Affiliations
Corresponding authors
Additional information
Chong Shi and Yongchao Ma have contributed equally to this work.
Electronic supplementary material
Below is the link to the electronic supplementary material.
11010_2011_1128_MOESM1_ESM.tif
Fig. S1. Furin inhibitor reduces pro-MT1-MMP cleavage. HPAC cells were cultured in RPMI 1640 containing 10% FBS at 37°C. Cells were treated with control or Furin inhibitor I (10 μM) for 2 h and Western blot was performed to detect MT1-MMP cleavage. The level of mature form of MT1-MMP decreased significantly in Furin inhibitor I-treated cells. (TIFF 157 kb)
11010_2011_1128_MOESM2_ESM.tif
Fig. S2. Furin inhibitor reduced cell surface expression of MT1-MMP. Control and Furin inhibitor I-treated HPAC cells were incubated with anti-MT1-MMP anti-goat antibody, and stained with FITC-labeled anti-goat second antibody (Green). DAPI was used for nuclear staining. The cells were observed with a confocal microscope (Leica Microsystems, LAS AF-TCS SP5). Scale bars, 25 μM. (TIFF 434 kb)
Rights and permissions
About this article
Cite this article
Shi, C., Ma, Y., Liu, H. et al. The non-receptor tyrosine kinase c-Src mediates the PDGF-induced association between Furin and pro-MT1-MMP in HPAC pancreatic cells. Mol Cell Biochem 362, 65–70 (2012). https://doi.org/10.1007/s11010-011-1128-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11010-011-1128-3